Hepatitis B virus reverse transcriptase – Target of current antiviral therapy and future drug development
Author:
Funder
Public Health Service
National Research Service Award
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference79 articles.
1. Inhibition of hepatitis B virus by a novel l-nucleoside, 2′-fluoro-5-methyl-beta-l-arabinofuranosyl uracil;Balakrishna Pai;Antimicrob. Agents Chemother.,1996
2. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription;Bartenschlager;Embo J.,1988
3. A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein;Beck;J. Virol.,2011
4. Chronic hepatitis B: a wave of new therapies on the horizon;Block;Antiviral Res.,2015
5. Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro;Boregowda;J. Virol.,2011
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection;JHEP Reports;2024-02
2. Conditional replication and secretion of hepatitis B virus genome uncover the truncated 3′ terminus of encapsidated viral pregenomic RNA;Journal of Virology;2023-10-31
3. Increasing hepatitis B vaccination coverage and decreasing hepatitis B co‐infection prevalence among people with HIV‐1 in Germany, 1996–2019. Results from a cohort study primarily in men who have sex with men;HIV Medicine;2023-10-02
4. Pharmacophore-Based Virtual Screening and Structural Modification of Novel Benzamide Derivatives as HBV Capsid Assembly Modulators;Biological and Pharmaceutical Bulletin;2023-09-01
5. Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials;Arabian Journal of Chemistry;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3